Results 31 to 40 of about 104,112 (336)

Trigeminovascular effects of propranolol in men and women, role for sex steroids

open access: yesAnnals of Clinical and Translational Neurology, 2022
Objective Assess whether propranolol modulates the trigeminovascular system in both men and women. Methods We investigated the effect of propranolol (80 mg, 90 min after oral administration, corresponding to Tmax) on the increase in dermal blood flow of ...
Eloísa Rubio‐Beltrán   +10 more
doaj   +1 more source

Low-Dose Propranolol Prevents Functional Decline in Catecholamine-Induced Acute Heart Failure in Rats

open access: yesToxics, 2022
Severe hyper-catecholaminergic states likely cause heart failure and cardiac fibrosis. While previous studies demonstrated the effects of beta-blockade in experimental models of single-catecholamine excess states, the detailed benefits of beta-blockade ...
Cheng-Ken Tsai   +6 more
doaj   +1 more source

Efficacy and safety assessment of propranolol tablets vs. oral solution for infantile hemangioma: a retrospective study in China

open access: yesFrontiers in Pediatrics
BackgroundPropranolol for infantile hemangiomas (IHs) is effective and relatively safe. However, propranolol has different formulations and there is no consensus on the optimal formulation for IHs.
Wenting Chen   +8 more
doaj   +1 more source

Involvement of propranolol in suicides: cross-sectional study using coroner-reported data

open access: yesBJPsych Open
Background Propranolol is a beta-blocker medication indicated mostly for heart rhythm conditions and for physical symptoms of anxiety. Prescriptions for propranolol in the UK have increased since 2008.
Hayley C. Gorton   +4 more
doaj   +1 more source

The effect of Midazolam and Propranolol on fear memory reconsolidation in ethanol-withdrawn rats: Influence of D-cycloserine [PDF]

open access: yes, 2014
Background: Withdrawal from chronic ethanol facilitates the formation of contextual fear memory and delays the onset to extinction, with its retrieval promoting an increase in ethanol consumption.
Espejo, Pablo Javier   +4 more
core   +1 more source

The use of non-selective beta-blockers in patients with cirrhosis: more doubts than certainties [PDF]

open access: yes, 2017
In conclusion, prospective RCT would be needed on the use of NSBBs in decompensated cirrhotic patients with ascites however these trials are difficult to organize and will need a large sample size.
Di Gregorio, Vincenza   +3 more
core   +1 more source

Propranolol in Treatment of Huge and Complicated Infantile Hemangiomas in Egyptian Children

open access: yesDermatology Research and Practice, 2014
Background. Infantile hemangiomas (IHs) are the most common benign tumours of infancy. Propranolol has recently been reported to be a highly effective treatment for IHs.
Basheir A. Hassan, Khalid S. Shreef
doaj   +1 more source

Deep coma in a child treated with propranolol for infantile hemangioma

open access: yesBMC Pediatrics, 2019
Background Propranolol hydrochloride is the first-line agent recommended for the treatment of infantile hemangiomas (IH). Serious adverse effects of propranolol therapy for hemangiomas are infrequent.
Ilirjana Bakalli   +7 more
doaj   +1 more source

Copper‐based Materials for Photo and Electrocatalytic Process: Advancing Renewable Energy and Environmental Applications

open access: yesAdvanced Functional Materials, EarlyView.
Cu‐based catalysts as a cornerstone in advancing sustainable energy technologies are fully reviewed in this manuscript, highlighting their potential in photo‐ and electrocatalysis. It includes metallic copper, copper oxides, copper sulfides, copper halide perovskites, copper‐based metal–organic frameworks (MOFs), and covalent organic frameworks (COFs),
Jéssica C. de Almeida   +16 more
wiley   +1 more source

The impact of propranolol on nitric oxide and total antioxidant capacity in patients with resistant hypertension—evidence from the APPROPRIATE trial

open access: yesBMC Research Notes, 2020
Objectives The objective was to assess the effect of propranolol on oxidative stress and anti-oxidant potential in patients with resistant hypertension as a secondary analysis of the APPROPRIATE trial.
H. N. Ranasinghe   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy